ROCHESTER, Minn., March 13, 2026 /PRNewswire/ -- Nanodropper Inc. today announced the launch of the Eye Drop Score, a first-of-its-kind self-check quiz designed to help people who rely on prescription ...

If you purchased any of these eye drops, stop using them. To get a refund for your purchase, AvKare states that you must complete the "Quantity to Return" column and customer information block on its ...

Beware! PHMB in your eye drops could be secretly harming your ocular surface. PHMB is a powerful antimicrobial preservative ...

Several companies have recently recalled their eye drops due to contamination concerns. Contaminated eye drops can present several risks—including the risk of a fatal bacterial infection in some cases ...

Add Yahoo as a preferred source to see more of our stories on Google. A person with long dark brown hair and silver hoop earrings applying eye drops into their left eye. Having dry, itchy, red eyes ...

An optometrist shares why this seemingly harmless item can lead to bigger issues with your eye health.

Using pilocarpine eye drops following Kahook Dual Blade (KDB) goniotomy surgery may improve clinical outcomes for patients with glaucoma and reduce the need for future medications, according to new ...

While eye drops may help alleviate some symptoms of diabetic retinopathy, they don’t target the underlying blood vessel damage in your retina. Retinopathy is a possible complication of diabetes. At ...

Having dry, itchy, red eyes caused by allergies, cold, dry weather, contact lenses or specific medical conditions can be frustrating. But one product that can provide relief is eye drops, which you ...

According to the Food and Drug Administration, over 75,000 cases of AvKare eye drops and artificial tears were recalled due to deviations from Current Good Manufacturing Practices (cGMP). CGMP ...

While eye drops can help with diabetes-related symptoms, such as dry eyes or irritation, they do not treat the underlying retinopathy. Diabetic retinopathy is a diabetes-related complication that ...